Some patients receive gratifying changes in their pigmentation and skin tone and some are minimally affected
Do you think GLP-1 drugs are upending this long-held idea that losing weight comes down to willpower
A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomized placebo-controlled trial

Injectable vs intranasal Selank Intranasal Selank (most common): Bioavailability: 60-70% Dose: 300-600mcg per nostril, 1-2x daily Very convenient Fast onset (15-30 minutes) No needles required Most users start here Injectable Selank: Bioavailability: 80-90% (higher) Dose: 250-1,000mcg daily subcutaneous More predictable absorption Slightly longer duration Requires injection skill More cost-effective per dose Why someone would choose injectable: Nasal irritation from intranasal use Want higher bioavailability Already comfortable with injections More precise dosing Combining with other injectable peptides Cost considerations Effectiveness comparison: Both highly effective Injectable slightly more potent per mcg Difference is modest Personal preference matters most See our injectable vs oral peptides comparison and peptides for anxiety guide for comprehensive anxiety protocols
As the first oral GLP-1 approved for weight management, it provides similar efficacy to injectable versions